Tchekalarova Jana, Sotiriou Evangelos, Georgiev Vasil, Kostopoulos George, Angelatou Fevronia
Laboratory of Experimental Psychopharmacology, Institute of Physiology, Acad. G. Bonchev Str., Bl. 23, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria.
Brain Res. 2005 Jan 25;1032(1-2):94-103. doi: 10.1016/j.brainres.2004.11.004.
The effects of the hexapeptide angiotensin II (3-8) ANG IV, the selective A(1) receptor agonist cyclohexyladenosine (CHA) and the combination of ANG IV + CHA on pentylenetetrazol (PTZ)-generalized seizures; kindling development and maintenance were studied. By using in vitro quantitative receptor autoradiography, the regulation of adenosine A(1) receptor density at different time points during the kindling procedure and postkindling period was determined. ANG IV and CHA effectively reduced clonic seizures in PTZ-generalized seizure model, in PTZ-kindled mice as well as during kindling development and a week later by rechallenge with PTZ. Furthermore, coadministration of ANG IV and CHA had a strong anticonvulsant effect, both compounds acting synergistically. A significant increase of adenosine A(1) receptor density was detected in somatosensory cortex, hippocampus, amygdala and geniculate nuclei early in the kindling procedure (after the 3rd injection), which persisted at least 1 month after the end of kindling procedure. In addition, a delayed up-regulation of adenosine A(1) receptor binding was observed a week after kindling in the mamillary bodies and a month later in the motor cortex. The pretreatment with ANG IV caused a down-regulation of adenosine A(1) receptor density to the control level in most time points and brain areas. In conclusion, PTZ kindling-induced increase of adenosine A(1) receptor binding at different time points and in specific brain structures might represent an adaptive mechanism for coping with the hyperexcitability typical for this phenomenon. The antiepileptogenic effect of ANG IV could be realized partly through an adenosine-dependent mechanism.
研究了六肽血管紧张素 II(3 - 8)即血管紧张素 IV(ANG IV)、选择性 A(1) 受体激动剂环己基腺苷(CHA)以及 ANG IV 与 CHA 的组合对戊四氮(PTZ)诱导的全身性癫痫发作、点燃发展及维持的影响。通过体外定量受体放射自显影术,测定了点燃过程及点燃后不同时间点腺苷 A(1) 受体密度的调节情况。ANG IV 和 CHA 能有效减少 PTZ 全身性癫痫发作模型、PTZ 点燃小鼠以及点燃发展过程中及一周后再次用 PTZ 激发时的阵挛性发作。此外,ANG IV 和 CHA 联合给药具有强大的抗惊厥作用,两种化合物协同发挥作用。在点燃过程早期(第 3 次注射后),在体感皮层、海马体、杏仁核和膝状核中检测到腺苷 A(1) 受体密度显著增加,这种增加在点燃过程结束后至少持续 1 个月。此外,在点燃一周后在乳头体中观察到腺苷 A(1) 受体结合的延迟上调,在运动皮层中则在一个月后出现。在大多数时间点和脑区,用 ANG IV 预处理可使腺苷 A(1) 受体密度下调至对照水平。总之,PTZ 点燃诱导的不同时间点及特定脑结构中腺苷 A(1) 受体结合增加可能代表了一种应对该现象典型的过度兴奋的适应性机制。ANG IV 的抗癫痫发生作用可能部分通过腺苷依赖性机制实现。